Margaret Mulligan

2010

In 2010, Margaret Mulligan earned a total compensation of $6.7M as Executive Vice, President, Chief Financial Officer at Valeant Pharmaceuticals International, a 276% increase compared to previous year.

Compensation breakdown

Option Awards$1,394,250
Salary$472,917
Stock Awards$1,429,938
Other$3,400,435
Total$6,697,540

Mulligan received $3.4M in other compensation, accounting for 51% of the total pay in 2010.

Mulligan also received $1.4M in option awards, $472.9K in salary and $1.4M in stock awards.

Rankings

In 2010, Margaret Mulligan's compensation ranked 645th out of 10,439 executives tracked by ExecPay. In other words, Mulligan earned more than 93.8% of executives.

ClassificationRankingPercentile
All
645
out of 10,439
94th
Division
Manufacturing
225
out of 3,837
94th
Major group
Chemicals And Allied Products
54
out of 923
94th
Industry group
Drugs
33
out of 682
95th
Industry
Pharmaceutical Preparations
28
out of 480
94th
Source: SEC filing on April 14, 2011.

Mulligan's colleagues

We found eight more compensation records of executives who worked with Margaret Mulligan at Valeant Pharmaceuticals International in 2010.

2010

William Wells

Valeant Pharmaceuticals International

Chief Executive Officer

2010

Gilbert Godin

Valeant Pharmaceuticals International

Chief Operating Officer

2010

Gregory Gubitz

Valeant Pharmaceuticals International

General Counsel

2010

J Pearson

Valeant Pharmaceuticals International

Chief Executive Officer

2010

Rajiv De Silva

Valeant Pharmaceuticals International

Chief Operating Officer

2010

Robert Chai-Onn

Valeant Pharmaceuticals International

General Counsel

2010

Mark Durham

Valeant Pharmaceuticals International

Senior Vice President, Human Resources

2010

Philip Loberg

Valeant Pharmaceuticals International

Chief Financial Officer

You may also like